Showing results (161-170 of 325) with videos related to
Sort By:
Pageof 33
International Journal of Hematology|March 17, 2016
Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroidsShiho Fujiwara, Hiromi Mochinaga, Hirotomo Nakata, et al.Journal of Virology|September 3, 2010
In vitro selection of highly darunavir-resistant and replication-competent HIV-1 variants by using a mixture of clinical HIV-1 isolates resistant to multiple conventional protease inhibitorsYasuhiro Koh, Masayuki Amano, Tomomi Towata, et al.ACS Medicinal Chemistry Letters|January 8, 2019
Synthesis, Anti-HBV, and Anti-HIV Activities of 3'-Halogenated Bis(hydroxymethyl)-cyclopentenyladeninesHiroki Kumamoto, Shuhei Imoto, Masayuki Amano, et al.Antiviral Chemistry & Chemotherapy|July 23, 2004
Attempt to reduce cytotoxicity by synthesizing the L-enantiomer of 4'-C-ethynyl-2'-deoxypurine nucleosides as antiviral agents against HIV and HBVKenji Kitano, Satoru Kohgo, Kohei Yamada, et al.Journal of Virology|August 5, 2011
Loss of protease dimerization inhibition activity of darunavir is associated with the acquisition of resistance to darunavir by HIV-1Yasuhiro Koh, Manabu Aoki, Matthew L Danish, et al.Journal of Medicinal Chemistry|May 13, 2005
Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitorsArun K Ghosh, Lisa M Swanson, Hanna Cho, et al.Biorxiv : the Preprint Server for Biology|June 15, 2022
SARS-CoV-2-neutralizing humoral IgA response occurs earlier but modest and diminishes faster compared to IgG responseYuki Takamatsu, Kazumi Omata, Yosuke Shimizu, et al.Scientific Reports|March 20, 2019
Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1sHirotomo Nakata, Kenji Maeda, Debananda Das, et al.Nucleosides, Nucleotides & Nucleic Acids|September 14, 2019
Synthesis and evaluation of the anti-hepatitis B virus activity of 4'-Azido-thymidine analogs and 4'-Azido-2'-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agentKengo Onitsuka, Ryoh Tokuda, Nobuyo Kuwata-Higashi, et al.Journal of Medicinal Chemistry|July 11, 2006
Design, synthesis, and biological evaluation of the combinatorial library with a new spirodiketopiperazine scaffold. Discovery of novel potent and selective low-molecular-weight CCR5 antagonistsHiromu Habashita, Masaya Kokubo, Shin-ichi Hamano, et al.Pageof 33